This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
And one of the highest areas of opportunity for human error is in the sterilecompounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations. savings per year.
Terri Albarano, PharmD Director, Autonomous Pharmacy, OmnicellSterilecompounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. billion in associated costs.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterilecompounded products? Or the airlines lost 10% of passenger bags.
Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterilecompounding needs. 23 at 1 pm ET.
David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterilecompounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.
Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Read more about the Omnicell-AHN Partnership in this week’s press release.
The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compoundedsterile products (CSPs) and instead allow users of self-enclosed robotic devices to surface sample once per day.
See how Omnicell is transforming pharmacy care at Booth #1213 in the Exhibit Hall, where you can explore our full portfolio of services for central pharmacy and IV compounding robotics, point-of-care dispensing, inventory optimization, specialty pharmacy, and retail pharmacy. And Omnicell is more than a vendor.
Dennis Wright Senior Director, Product Marketing, Omnicell For more than 15 years, IV robotics has proven efficacy in safe and efficient sterilecompounding, but market adoption has been limited. A new era of IV robotics in the IVX Station , new technology introduced as part of Omnicell's Winter 2022 Release.
Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterilecompounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterilecompounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.
We recognized the patient safety benefits of IV compounding automation , including IV compounding robot , but were concerned about staffing this new technology. Omnicell's IV compounding robot service offered the holistic solution we needed.
A recent Institute for Safe Medication Practices (ISMP) article breaks the numerous risks associated with manual sterilecompounding processes into three main categories: Potential for contamination, leading to possible patient infections. It’s one of the riskiest processes in the pharmacy department.
Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.
Ken Osborn Senior Director, Product Marketing, Omnicell As medication management continues to be one of the top challenges of healthcare today, Omnicell’s commitment to delivering the innovation to navigate and streamline the complexities of the pharmacy care delivery model is stronger than ever.
Four IV robots produce non-hazardous medications 15 hours a day, Monday through Thursday, outsourcing technician manpower through Omnicell's IV Compounding Service. We insource about 50 percent of our non-hazardous adult sterile products, producing about 750 doses per day and 3,000 per week.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.
Omnicell is partnering with the Autonomous Pharmacy Advisory Board to transform the pharmacy care model through technology-enabled solutions and delivering expert services, supporting the journey to “zero error” through the Autonomous Pharmacy.
In fact, in a 2020 ISMP SterileCompounding Pulse Check conducted with 634 pharmacy practitioners, only 25% of respondents report using technologies that include barcode verification, images, and gravimetric verification for 50% of compoundedsterile products.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content